Nevada Biotechnology & Bioscienceconsortium
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 10,742 | 13,652 | −2,910 | -5.4 | — |
| 2012 | 11,706 | 17,614 | −5,908 | -8.2 | — |
| 2013 | 8,675 | 11,513 | −2,838 | -15.5 | — |
| 2014 | 42,344 | 41,653 | 691 | -4.1 | — |
| 2015 | 93,946 | 73,064 | 20,882 | 1.1 | — |
| 2016 | 69,532 | 51,744 | 17,788 | 5.7 | — |
| 2017 | 102,178 | 81,012 | 21,166 | 6.8 | — |
| 2018 | 155,339 | 106,167 | 49,172 | 10.7 | — |
| 2019 | 155,393 | 100,496 | 54,897 | 17.9 | — |
| 2020 | 145,951 | 77,550 | 68,401 | 33.8 | — |
| 2021 | 161,297 | 86,499 | 74,798 | 40.6 | — |
| 2022 | 168,762 | 101,726 | 67,036 | 42.5 | — |
| 2023 | 146,041 | 91,414 | 54,627 | 54.4 | — |
In its most recent public year (2023), this organization brought in $54,627 more than it spent. Its reserves stood at about 54.4 months of spending, up from -5.4 in 2011.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Nevada Biotechnology & Bioscienceconsortium's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works